A campaign worth joining: Improving outcome in severe sepsis and septic shock using the surviving sepsis - Campaign guidelines

Southern Medical Journal

Volumn 100, Issue 6, 2007, Pages 557-558

  Patel, Gourang P ^a   Elpern, Ellen H ^a   Balk, Robert A ^a,b  

^a RUSH MEDICAL COLLEGE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DROTRECOGIN; HYPERTENSIVE FACTOR;

ARTIFICIAL VENTILATION; EDITORIAL; FLUID RESUSCITATION; GRAM POSITIVE BACTERIUM; HUMAN; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; SEPSIS; SEPTIC SHOCK;

HUMANS; PRACTICE GUIDELINES; SHOCK, SEPTIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UNITED STATES;

EID: 34250695431     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e3180315d75     Document Type: Editorial

References (14)

1. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: the ACCP/SCCM Consensus Conference Committee. Chest 1992;101:1644-1655.
2. Balk RA. Optimum treatment of severe sepsis and septic shock: evidence in support of the recommendations. Disease-a-Month 2004;50:163-214.
3. Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-1554.
4. Brun-Buisson C, Doyon F, Carlet J, et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: a multicenter, prospective study in intensive care units: French ICU group for severe sepsis. JAMA 1995;274:968-974.
5. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-1310.
6. Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858-873.
7. Gao F, Melody T, Daniels DF, et al. The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study. Crit Care 2005;9:R764-R770.
8. Trzeciak S, Dellinger RP, Abate NL, et al. Translating research to clinical practice: a 1-year experience with implementing early goal-directed therapy to septic shock in the emergency department. Chest 2006;129:225-232.
9. Keh D, Sprung CL. Use of corticosteroid therapy in patients with sepsis and septic shock: an evidence-based review. Crit Care Med 2004;32:S527-S533.
10. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Eng J Med 2001;345:1359-1367.
11. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449-461.
12. Fourrier F. Recombinant human activated protein C in the treatment of severe sepsis: an evidence-based review. Crit Care Med 2004;32:S534-S541.
13. De Miguel-Yanes JM, Andueza-Lillo JA, Gonzalez-Ramallo VJ, et al. Failure to implement evidence-based clinical guidelines for sepsis at the ED. Am J Emerg Med 2006;24:553-559.
14. Garland A. Improving the ICU: part 2. Chest 2005;127:2165-2179.